Defining the antihypertensive properties of the angiotensin receptor blocker telmisartan by a practice-based clinical trial.

[1]  F. Messerli,et al.  Combination therapy of amlodipine/benazepril versus monotherapy of amlodipine in a practice-based setting. , 2002, American journal of hypertension.

[2]  M. Nieminen,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[3]  J. McGill,et al.  Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial. , 2001, Clinical therapeutics.

[4]  E. Michelson,et al.  Efficacy of candesartan cilexetil as add-on therapy in hypertensive patients uncontrolled on background therapy: a clinical experience trial. ACTION Study Investigators. , 2000, American journal of hypertension.

[5]  M. Burnier,et al.  Angiotensin II receptor antagonists in hypertension. , 1998, Kidney international. Supplement.

[6]  A. Markham,et al.  Irbesartan. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in the management of hypertension. , 1997, Drugs.

[7]  N. Kaplan.  The CARE Study: a postmarketing evaluation of ramipril in 11,100 patients. The Clinical Altace Real-World Efficacy (CARE) Investigators. , 1996, Clinical therapeutics.

[8]  B Bornkessel,et al.  [Angiotensin II receptor antagonists]. , 1995, Medizinische Monatsschrift fur Pharmazeuten.

[9]  P Whelton,et al.  Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. , 1995, Hypertension.

[10]  M. Weber,et al.  Clinical experience with the angiotensin II receptor antagonist losartan. A preliminary report. , 1992, American journal of hypertension.

[11]  J. Laragh,et al.  The vasoconstriction-volume spectrum in normotension and in the pathogenesis of hypertension. , 1982, Federation proceedings.

[12]  D. Roden,et al.  The genetic basis of variability in drug responses , 2002, Nature Reviews Drug Discovery.

[13]  H. Ward,et al.  Inadequate management of blood pressure in a hypertensive population. , 1999, New England Journal of Medicine.

[14]  Detection.  The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .

[15]  V. I. Metelitsa.  [Angiotensin-II receptor blockers]. , 1996, Terapevticheskii arkhiv.

[16]  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. , 1991, JAMA.

[17]  T. Goodfriend,et al.  Angiotensin Receptors , 1994, Springer US.